Capricor Therapeutics (CAPR) has an average rating of overweight and mean price target of $31.78, according to analysts polled by FactSet.
What else is happening in Research?
Research
AlphaValue/Baader Europe Upgrades Travis Perkins to Add, Trims PT
AlphaValue/Baader Europe on Friday upgraded building materials group Travis Perkins (TPK.L) to add from reduce and decreased its price target to 6.59 pounds sterling from 6.65 pounds.
$TPK.L
Research
BNP Paribas Cuts Rheinmetall's PT, Affirms Outperform Rating
BNP Paribas on Thursday reduced the price target for German defense technology company Rheinmetall (RHM.F) to 1,600.00 euros from 2,200.00 euros and reiterated its outperform rating.
$RHM.F
Research
Goldman Sachs Keeps Shell at Buy, Lifts PT
Goldman Sachs on Thursday increased the price target for oil and gas giant Shell (SHEL.L, SHELL.AS) to 53 euros from 50 euros, while confirming its buy rating.
$SHEL.L$SHELL.AS